ADVISORY/Reminyl, New Treatment for Alzheimer's Disease, Receives FDA Approval.Business Editors & Health/Medical Writers ADVISORY...for Wednesday (Feb. 28) NOTE TO EDITORS: Multimedia Assets Available With This Story Include Graphics, Logos, Photos, Text news releases, Video --(BUSINESS WIRE)-- Reminyl(R) (galantamine hydrobromide galantamine hydrobromide Razadyne, Razadyne ER, Reminyl (UK) Pharmacologic class: Cholinesterase inhibitor Therapeutic class: Anti-Alzheimer's agent Pregnancy risk category B Action)a new treatment for mild to moderate Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. derived from the bulbs of daffodils -- was approved Feb. 28 by the U.S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ). You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?2218 This multimedia news story is for free and unrestricted use on your news information site (and for print or broadcast too). Visit http://www.newstream.com to download To receive a file transmitted over a network. In any communications session, "download" means receive, and "upload" means send. The download/upload often implies a big/little scenario, in which data is being downloaded from the "big" server into the "little" user's computer. video, audio, text, graphics and photos. If you have any questions about the story, or about Newstream.com, please write to us at info@newstream.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion